MedySapiens

Innovating Digital

Healthcare through

AI-driven Genomics

SCROLL

SOLUTIONS

NEOseq_ACTION®

NEOseq_ACTION® is a reagent that examines single nucleotide variants of 265 genes related to actionable genetic rare diseases.Through NEOseq_ACTION®, DNA can be extracted from 1 dried blood spot (DBS) or 100 μl of blood from a child, and 265 genes can be tested at once through Next Generation Sequencing.

CONTACT

Address

B-1010, 11, Beobwon-ro 11-gil (Munjeong Hyundai Knowledge Industry Center 1-1), Songpa-gu, Seoul, Korea, 05836

Phone

+82-70-7701-0064

Email

info@medysapiens.com